Global Clinical Trials: Considering Translation in Your Risk Analysis (podcast)
|
Two recent trends in the pharmaceutical industry are bringing increased attention to the risks involved in global clinical trials:
- Regulators are demanding larger population pools and longer-term monitoring
- Trials companies are pushing clinical trial boundaries across the globe into the ascending markets of Eastern Europe, Asia, and Latin America
|
|
 |
According to Thomson CenterWatch, 20-30 percent of clinical trials are being conducted in ascending regions. Countries such as India and China, though popular from a cost and patient recruitment efficiency perspective, bring special language challenges to consider during the Clinical Trials planning process.
Listen as Mark Wade, Life Sciences Practice Leader at Lionbridge, explores:
- Trends in translation within the pharmaceutical industry
- Risks and challenges in clinical trials when involving language translation
- Importance of process and translator certification
- Hot spots for global clinical trials and managing the accompanying language complexities
This 11-minute podcast, produced by Future Pharmaceuticals, provides a quick overview of risks involved in global clinical trials translation.